Medtronic Cost of Goods Sold 2010-2024 | MDT
Medtronic annual/quarterly cost of goods sold history and growth rate from 2010 to 2024. Cost of goods sold can be defined as the difference between beginning and ending inventories for tangible products resulting in an expense that reflects production and sales costs.
- Medtronic cost of goods sold for the quarter ending January 31, 2024 was $2.782B, a 3.46% increase year-over-year.
- Medtronic cost of goods sold for the twelve months ending January 31, 2024 was $11.150B, a 7.93% increase year-over-year.
- Medtronic annual cost of goods sold for 2023 was $10.719B, a 5.66% increase from 2022.
- Medtronic annual cost of goods sold for 2022 was $10.145B, a 3.22% decline from 2021.
- Medtronic annual cost of goods sold for 2021 was $10.483B, a 11.24% increase from 2020.
| Medtronic Annual Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2023 | $10,719 |
| 2022 | $10,145 |
| 2021 | $10,483 |
| 2020 | $9,424 |
| 2019 | $9,155 |
| 2018 | $9,067 |
| 2017 | $9,294 |
| 2016 | $9,142 |
| 2015 | $6,309 |
| 2014 | $4,333 |
| 2013 | $4,126 |
| 2012 | $3,889 |
| 2011 | $3,700 |
| 2010 | $3,582 |
| 2009 | $3,518 |
| Medtronic Quarterly Cost of Goods Sold (Millions of US $) |
|
|---|---|
| 2024-01-31 | $2,782 |
| 2023-10-31 | $2,761 |
| 2023-07-31 | $2,628 |
| 2023-04-30 | $2,979 |
| 2023-01-31 | $2,689 |
| 2022-10-31 | $2,535 |
| 2022-07-31 | $2,516 |
| 2022-04-30 | $2,591 |
| 2022-01-31 | $2,459 |
| 2021-10-31 | $2,497 |
| 2021-07-31 | $2,598 |
| 2021-04-30 | $2,652 |
| 2021-01-31 | $2,621 |
| 2020-10-31 | $2,705 |
| 2020-07-31 | $2,505 |
| 2020-04-30 | $2,264 |
| 2020-01-31 | $2,400 |
| 2019-10-31 | $2,394 |
| 2019-07-31 | $2,366 |
| 2019-04-30 | $2,483 |
| 2019-01-31 | $2,265 |
| 2018-10-31 | $2,203 |
| 2018-07-31 | $2,204 |
| 2018-04-30 | $2,398 |
| 2018-01-31 | $2,194 |
| 2017-10-31 | $2,123 |
| 2017-07-31 | $2,352 |
| 2017-04-30 | $2,439 |
| 2017-01-31 | $2,268 |
| 2016-10-31 | $2,326 |
| 2016-07-31 | $2,261 |
| 2016-04-30 | $2,363 |
| 2016-01-31 | $2,141 |
| 2015-10-31 | $2,182 |
| 2015-07-31 | $2,456 |
| 2015-04-30 | $2,934 |
| 2015-01-31 | $1,128 |
| 2014-10-31 | $1,142 |
| 2014-07-31 | $1,105 |
| 2014-04-30 | $1,171 |
| 2014-01-31 | $1,050 |
| 2013-10-31 | $1,090 |
| 2013-07-31 | $1,022 |
| 2013-04-30 | $1,134 |
| 2013-01-31 | $999 |
| 2012-10-31 | $1,020 |
| 2012-07-31 | $973 |
| 2012-04-30 | $1,047 |
| 2012-01-31 | $931 |
| 2011-10-31 | $960 |
| 2011-07-31 | $951 |
| 2011-04-30 | $912 |
| 2011-01-31 | $934 |
| 2010-10-31 | $961 |
| 2010-07-31 | $893 |
| 2010-04-30 | $782 |
| 2010-01-31 | $912 |
| 2009-10-31 | $922 |
| 2009-07-31 | $966 |
| 2009-04-30 | $932 |
| 2009-01-31 | $848 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Products Manufacturing | $113.715B | $31.227B |
| Medtronic, Inc. acquired Ireland-based Covidien plc. The acquisition resulted in the formation of a new holding company incorporated in Ireland - Medtronic plc. The company currently generates revenues from four major segments - namely Cardiovascular Portfolio, Medical Surgical Portfolio, Neuroscience Portfolio and Diabetes. The Cardiovascular Portfolio, formerly reported as the Cardiac and Vascular Group, includes the Cardiac Rhythm & Heart Failure, Structural Heart & Aortic and Coronary & Peripheral Vascular divisions. The Medical Surgical Portfolio, formerly reported as the Minimally Invasive Therapies Group, includes the Surgical Innovations and the Respiratory, Gastrointestinal & Renal divisions. Neuroscience consists of Cranial & Spinal Technologies, Specialty The Neuroscience Portfolio, formerly reported as the Restorative Therapies Group, includes the Cranial & Spinal Technologies, Specialty Therapies, and Neuromodulation divisions. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Abbott Laboratories (ABT) | United States | $182.435B | 23.89 |
| Stryker (SYK) | United States | $127.230B | 30.47 |
| Boston Scientific (BSX) | United States | $109.372B | 34.84 |
| EssilorLuxottica (ESLOY) | France | $101.565B | 0.00 |
| Lonza Group Ag (LZAGY) | Switzerland | $43.132B | 0.00 |
| Haleon (HLN) | United Kingdom | $38.219B | 27.90 |
| ResMed (RMD) | United States | $32.315B | 30.34 |
| Terumo (TRUMY) | Japan | $26.460B | 37.37 |
| Koninklijke Philips (PHG) | Netherlands | $25.501B | 19.75 |
| Zimmer Biomet Holdings (ZBH) | United States | $24.940B | 15.93 |
| Baxter (BAX) | United States | $17.922B | 12.74 |
| Insulet (PODD) | United States | $12.984B | 57.57 |
| Smith & Nephew SNATS (SNN) | United Kingdom | $11.301B | 0.00 |
| Demant (WILYY) | Denmark | $10.234B | 0.00 |
| Bio-Rad Laboratories (BIO) | United States | $8.436B | 27.59 |
| BellRing Brands (BRBR) | United States | $7.595B | 35.72 |
| Lantheus Holdings (LNTH) | United States | $5.621B | 14.01 |
| Haemonetics (HAE) | United States | $4.815B | 23.82 |
| GN Store Nord (GNNDY) | Denmark | $4.400B | 24.71 |
| Perrigo (PRGO) | Ireland | $4.103B | 12.44 |
| Envista Holdings (NVST) | United States | $3.288B | 13.57 |
| Prestige Consumer Healthcare (PBH) | United States | $3.244B | 15.44 |
| QuidelOrtho (QDEL) | United States | $2.946B | 16.35 |
| Neogen (NEOG) | United States | $2.905B | 27.94 |
| Maravai LifeSciences Holdings (MRVI) | United States | $2.791B | 0.00 |
| Green Thumb Industries (GTBIF) | United States | $2.760B | 54.67 |
| TG Therapeutics (TGTX) | United States | $2.692B | 75.74 |
| ICU Medical (ICUI) | United States | $2.589B | 22.85 |
| Agios Pharmaceuticals (AGIO) | United States | $1.987B | 0.00 |
| Verano Holdings (VRNOF) | United States | $1.828B | 0.00 |
| LeMaitre Vascular (LMAT) | United States | $1.744B | 51.10 |
| Warby Parker (WRBY) | United States | $1.600B | 0.00 |
| InMode (INMD) | Israel | $1.565B | 8.32 |
| Owens & Minor (OMI) | United States | $1.462B | 12.74 |
| AdaptHealth (AHCO) | United States | $1.312B | 9.75 |
| National Vision Holdings (EYE) | United States | $1.258B | 40.03 |
| AtriCure (ATRC) | United States | $1.077B | 0.00 |
| BioLife Solutions (BLFS) | United States | $1.011B | 0.00 |
| Canopy Growth (CGC) | Canada | $0.926B | 0.00 |
| Evolus (EOLS) | United States | $0.858B | 0.00 |
| Cresco Labs (CRLBF) | United States | $0.767B | 0.00 |
| Phibro Animal Health (PAHC) | United States | $0.728B | 15.50 |
| Quanterix (QTRX) | United States | $0.664B | 0.00 |
| VAREX IMAGING (VREX) | United States | $0.623B | 14.65 |
| Valneva SE (VALN) | France | $0.614B | 0.00 |
| PetIQ (PETQ) | United States | $0.583B | 19.05 |
| TerrAscend (TSNDF) | Canada | $0.525B | 0.00 |
| Jin Medical (ZJYL) | China | $0.507B | 0.00 |
| Surmodics (SRDX) | United States | $0.486B | 30.43 |
| ZimVie (ZIMV) | United States | $0.463B | 39.49 |
| Aurora Cannabis (ACB) | Canada | $0.415B | 0.00 |
| OraSure Technologies (OSUR) | United States | $0.387B | 12.45 |
| Cerus (CERS) | United States | $0.362B | 0.00 |
| Biote (BTMD) | United States | $0.362B | 8.34 |
| Zynex (ZYXI) | United States | $0.350B | 47.83 |
| MacroGenics (MGNX) | United States | $0.321B | 0.00 |
| Viemed Healthcare (VMD) | United States | $0.274B | 27.19 |
| Sanara MedTech (SMTI) | United States | $0.273B | 0.00 |
| TriSalus Life Sciences (TLSI) | United States | $0.260B | 0.00 |
| Utah Medical Products (UTMD) | United States | $0.249B | 15.66 |
| Ayr Wellness (AYRWF) | United States | $0.222B | 0.00 |
| Organigram Holdings (OGI) | Canada | $0.210B | 0.00 |
| Veru (VERU) | United States | $0.201B | 0.00 |
| Omeros (OMER) | United States | $0.192B | 0.00 |
| High Tide (HITI) | Canada | $0.190B | 0.00 |
| Capricor Therapeutics (CAPR) | United States | $0.179B | 0.00 |
| Eagleford Energy (GRUSF) | United States | $0.167B | 80.00 |
| Quipt Home Medical (QIPT) | United States | $0.145B | 0.00 |
| InterCure (INCR) | Israel | $0.143B | 24.19 |
| Jushi Holdings (JUSHF) | United States | $0.142B | 0.00 |
| FitLife Brands (FTLF) | United States | $0.129B | 18.29 |
| Cellectar Biosciences (CLRB) | United States | $0.119B | 0.00 |
| Fonar (FONR) | United States | $0.099B | 8.54 |
| MariMed (MRMD) | United States | $0.096B | 0.00 |
| Oramed Pharmaceuticals (ORMP) | United States | $0.095B | 0.00 |
| Brainsway (BWAY) | Israel | $0.090B | 0.00 |
| Allurion Technologies (ALUR) | United States | $0.089B | 0.00 |
| Chimerix (CMRX) | United States | $0.087B | 0.00 |
| Zevia PBC (ZVIA) | United States | $0.078B | 0.00 |
| Safety Shot (SHOT) | United States | $0.074B | 0.00 |
| Eagle Pharmaceuticals (EGRX) | United States | $0.062B | 4.03 |
| Apyx Medical (APYX) | United States | $0.053B | 0.00 |
| Rockwell Medical (RMTI) | United States | $0.053B | 0.00 |
| Cytosorbents (CTSO) | United States | $0.047B | 0.00 |
| Bright Green (BGXX) | United States | $0.043B | 0.00 |
| United-Guardian (UG) | United States | $0.043B | 15.62 |
| Modular Medical (MODD) | United States | $0.038B | 0.00 |
| ImmuCell (ICCC) | United States | $0.038B | 0.00 |
| Exagen (XGN) | United States | $0.033B | 0.00 |
| Nephros (NEPH) | United States | $0.024B | 0.00 |
| Agape ATP (ATPC) | $0.019B | 0.00 | |
| Meihua Medical Technologies (MHUA) | China | $0.019B | 0.00 |
| Flora Growth (FLGC) | United States | $0.017B | 0.00 |
| GlucoTrack (GCTK) | United States | $0.013B | 0.00 |
| FSD PHARMA (HUGE) | Canada | $0.013B | 0.00 |
| Trinity Biotech (TRIB) | Ireland | $0.012B | 0.00 |
| GUARDION HEALTH (GHSI) | United States | $0.011B | 0.00 |
| IM Cannabis (IMCC) | Canada | $0.010B | 0.00 |
| NeuroMetrix (NURO) | United States | $0.008B | 0.00 |
| Leafly Holdings (LFLY) | United States | $0.005B | 0.00 |
| Senestech (SNES) | United States | $0.004B | 0.00 |
| Sharps Technology (STSS) | United States | $0.003B | 0.00 |
| Lucy Scientific Discovery (LSDI) | Canada | $0.003B | 0.00 |
| Innovative Eyewear (LUCY) | United States | $0.003B | 0.00 |
| Akanda (AKAN) | United Kingdom | $0.001B | 0.00 |
| Smart For Life (SMFL) | United States | $0.000B | 0.00 |
| Bruush Oral Care (BRSH) | $0.000B | 0.00 | |
| SNDL (SNDL) | Canada | $0.000B | 0.00 |